反应详情

In a round-bottomed flask, 2-(5-chloro-1-methyl-1H-indazol-3-yl)-5-(2-trimethylsilanylethoxymethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid [(R)-1-(4-cyano-piperidine-1-carbonyl)-2,2-dimethyl-propyl]-amide (0.158 g, 0.193 mmol) was dissolved in dichloromethane (1 ml) and trifluoroacetic acid (0.6 ml, 7.8 mmol) was added. The reaction mixture was stirred at room temperature for 2 h then concentrated. The residue was redissolved in dichloromethane (1 ml) and ethylenediamine (0.8 ml, 11.7 mmol) was added. The solution was stirred at room temperature for 1 h then quenched with water and extracted with EtOAc (2×). The combined organic layers were washed with water and brine then dried over sodium sulfate, filtered and concentrated. The residue was purified by chromatography over silica gel with EtOAc/hexanes (gradient 0-100% EtOAc) to afford 26 mg (24%) of 2-(5-chloro-1-methyl-1H-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid [(R)-1-(4-cyano-piperidine-1-carbonyl)-2,2-dimethyl-propyl]-amide as an off-white solid. MS: (M+H)+=533; 1H NMR (DMSO-d6, 300 MHz): δ (ppm) 12.92 (br. s., 1H), 9.09 (s, 1H), 8.73 (d, J=6.8 Hz, 1H), 8.61 (t, J=8.1 Hz, 1H), 8.46 (d, J=9.1 Hz, 1H), 7.80 (d, J=9.1 Hz, 1H), 7.50 (d, J=9.1 Hz, 1H), 5.20 (d, J=9.4 Hz, 1H), 4.19 (s, 3H), 3.97-4.12 (m, 1H), 3.35-3.91 (m, 2H), 3.01-3.23 (m, 2H), 1.39-2.07 (m, 4H), 1.04 (d, J=6.4 Hz, 9H).

1. concentrationthen concentrated
2. dissolutionThe residue was redissolved in dichloromethane (1 ml)
3. stirringThe solution was stirred at room temperature for 1 h
4. customthen quenched with water
5. extractionextracted with EtOAc (2×)
6. washThe combined organic layers were washed with water and brine
7. dry with materialthen dried over sodium sulfate
8. filtrationfiltered
9. concentrationconcentrated
10. customThe residue was purified by chromatography over silica gel with EtOAc/hexanes (gradient 0-100% EtOAc)